Amorfix Life Sciences Ltd. - Financial and Strategic Analysis Review

Product Code GMD08964
Publication Date July 2009
Publisher Global Markets Direct
Product Type Report
Pages 16
Buy this product or for assistance call +44 20 7060 7474

Amorfix Life Sciences Ltd. - Financial and Strategic Analysis Review

Summary

Amorfix Life Sciences Ltd. (Amorfix) is a theranostics company engaged in developing therapeutic products and diagnostic devices for treatment of brain-wasting diseases such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, Parkinson's disease and variant Creutzfeldt - Jakob disease (vCJD). The company intends to develop diagnostic kits, biologic therapeutics, drug therapeutics, and prophylactics, such as vaccines for the treatment of aggregated misfolded proteins (AMP). The company's lead programs include a diagnostic blood screening test for vCJD and a therapy for ALS. The company is headquartered at Mississauga in Ontario, Canada.

Global Markets Direct's Amorfix Life Sciences Ltd. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Amorfix Life Sciences Ltd.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • List of Tables
  • List of Figures
    • Amorfix Life Sciences Ltd. - Key Facts
    • Amorfix Life Sciences Ltd. - Key Facts
    • Amorfix Life Sciences Ltd. - Business Description
    • Amorfix Life Sciences Ltd. - Major Products and Services
    • Amorfix Life Sciences Ltd. - History
    • Amorfix Life Sciences Ltd. - SWOT Analysis
    • SWOT Analysis - Overview
    • Amorfix Life Sciences Ltd. - Strengths
    • Strength - Strong Liquidity Position
    • Strength - Proprietary Epitope Protection Technology
    • Strength - Blood-Based Diagnostic Test
    • Strength - Technological Recognition
    • Amorfix Life Sciences Ltd. - Weaknesses
    • Weakness - Lack of Product Revenues
    • Weakness - Dependence on Collaborative Partners and Licensors
    • Amorfix Life Sciences Ltd. - Opportunities
    • Opportunity - Product Development
    • Opportunity - Strategic Collaborations and Agreements
    • Opportunity - Increasing Demand for Blood Products
    • Opportunity - Emerging Economies
    • Amorfix Life Sciences Ltd. - Threats
    • Threat - Tightening of the FDA's Regulatory Oversight
    • Threat - Impact of the Financial Crisis
    • Threat - Uncertainties in R&D
    • Threat - Increased Pricing Control
    • Amorfix Life Sciences Ltd. - Key Competitors
    • Amorfix Life Sciences Ltd. - Key Employees
    • Amorfix Life Sciences Ltd. - Key Employee Biographies
    • Amorfix Life Sciences Ltd. - Locations And Subsidiaries
    • Head Office
    • Amorfix Life Sciences Ltd. - Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
    • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Amorfix Life Sciences Ltd., Key Facts
    • Amorfix Life Sciences Ltd., Major Products and Services
    • Amorfix Life Sciences Ltd., History
    • Amorfix Life Sciences Ltd., Key Employees
    • Amorfix Life Sciences Ltd., Key Employee Biographies
    • Amorfix Life Sciences Ltd., Ratios based on current share price
    • Amorfix Life Sciences Ltd., Annual Ratios
    • Amorfix Life Sciences Ltd., Interim Ratios
  • List of Figures
    • Amorfix Life Sciences Ltd., Ratio Charts

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment